BNP Paribas Call 2500 GIVN 20.12..../ DE000PN7C5M0 /
14/06/2024 9:21:03 | Diferencia+0.060 | Bid9:38:37 | Ask9:38:37 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
19.230EUR | +0.31% | 19.480 Volumen de oferta: 6,500 |
19.500 Tamaño/ Volumen/ Formato de Ask: 6,500 |
GIVAUDAN N | 2,500.00 CHF | 20/12/2024 | Call |
GlobeNewswire
9:11
Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging ...
GlobeNewswire
9:01
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
9:00
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
9:00
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
9:00
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
8:00
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
7:00
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página